Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard W Peck

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|March 31, 2007
Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker developmentRichard W Peck
Annual Review of Pharmacology and Toxicology|September 30, 2017
Precision Medicine Is Not Just Genomics: The Right Dose for Every PatientRichard W Peck
Nature Reviews. Drug Discovery|December 17, 2015
The right dose for every patient: a key step for precision medicineRichard W Peck
Clinical Pharmacology and Therapeutics|October 27, 2020
Precision Dosing: An Industry PerspectiveRichard W Peck
Clinical Pharmacology and Therapeutics|February 8, 2024
Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug ResponsesThomas M Polasek, Richard W Peck
Clinical Pharmacology and Therapeutics|January 20, 2020
Model-Informed Artificial Intelligence: Reinforcement Learning for Precision DosingBenjamin Ribba, Sherri Dudal, Thierry Lavé, et al.
Clinical Pharmacology and Therapeutics|November 24, 2019
Organs-on-Chips in Clinical Pharmacology: Putting the Patient Into the Center of Treatment Selection and Drug DevelopmentRichard W Peck, Christopher D Hinojosa, Geraldine A Hamilton
Clinical Pharmacology and Therapeutics|February 22, 2021
Precision Dosing: The Clinical Pharmacology of GoldilocksRichard W Peck, Mohamed H Shahin, Alexander A Vinks
Plos One|February 15, 2023
Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndromeCristina Segú-Vergés, Laura Artigas, Mireia Coma, et al.
Clinical Pharmacology and Therapeutics|May 24, 2020
A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19Richard W Peck, Daniel Weiner, Jack Cook, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|March 31, 2007
Driving earlier clinical attrition: if you want to find the needle, burn down the haystack. Considerations for biomarker developmentRichard W Peck
Annual Review of Pharmacology and Toxicology|September 30, 2017
Precision Medicine Is Not Just Genomics: The Right Dose for Every PatientRichard W Peck
Nature Reviews. Drug Discovery|December 17, 2015
The right dose for every patient: a key step for precision medicineRichard W Peck
Clinical Pharmacology and Therapeutics|October 27, 2020
Precision Dosing: An Industry PerspectiveRichard W Peck
Clinical Pharmacology and Therapeutics|February 8, 2024
Beyond Population-Level Targets for Drug Concentrations: Precision Dosing Needs Individual-Level Targets that Include Superior Biomarkers of Drug ResponsesThomas M Polasek, Richard W Peck
Clinical Pharmacology and Therapeutics|January 20, 2020
Model-Informed Artificial Intelligence: Reinforcement Learning for Precision DosingBenjamin Ribba, Sherri Dudal, Thierry Lavé, et al.
Clinical Pharmacology and Therapeutics|November 24, 2019
Organs-on-Chips in Clinical Pharmacology: Putting the Patient Into the Center of Treatment Selection and Drug DevelopmentRichard W Peck, Christopher D Hinojosa, Geraldine A Hamilton
Clinical Pharmacology and Therapeutics|February 22, 2021
Precision Dosing: The Clinical Pharmacology of GoldilocksRichard W Peck, Mohamed H Shahin, Alexander A Vinks
Plos One|February 15, 2023
Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndromeCristina Segú-Vergés, Laura Artigas, Mireia Coma, et al.
Clinical Pharmacology and Therapeutics|May 24, 2020
A Real-World Evidence Framework for Optimizing Dosing in All Patients With COVID-19Richard W Peck, Daniel Weiner, Jack Cook, et al.
Pageof 3